Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway
Author:
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference25 articles.
1. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy;Baker;Regulatory Peptides,2004
2. Role of the JAK–STAT pathway in myocardial injury;Barry;Trends in Molecular Medicine,2007
3. Interplay between the cardiac renin angiotensin system and JAK–STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure;Booz;Journal of Molecular and Cellular Cardiology,2002
4. Cardiotrophin-1 in heart failure;Bristow;Circulation,2002
5. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor;Dechend;Circulation,2001
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Simvastatin Significantly Reduced Alcohol-Induced Cardiac Damage in Adolescent Mice;Cardiovascular Toxicology;2024-01
2. Effect and mechanism of HMG-CoA reductase inhibitor on the improvement of elderly essential hypertension-induced vascular endothelial function impairment based on the JAK/STAT pathway;Diagnostic Pathology;2023-09-28
3. RETRACTED ARTICLE: Simvastatin-loaded nano-niosomes efficiently downregulates the MAPK-NF-κB pathway during the acute phase of myocardial ischemia-reperfusion injury;Molecular Biology Reports;2022-09-12
4. Connection between JAK/STAT and PPARγ Signaling During the Progression of Multiple Sclerosis: Insights into the Modulation of T-Cells and Immune Responses in the Brain;Current Molecular Pharmacology;2021-12-16
5. Simvastatin-loaded nano-niosomes confer cardioprotection against myocardial ischemia/reperfusion injury;Drug Delivery and Translational Research;2021-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3